Co-stimulatory molecule CD80 expression may correlate with anti-HCV treatment outcome.
Sacchi
A
A
Agrati
C
C
D'Offizi
G
G
Vlassi
Chrysoula
C
Martini
F
F
D000998:Antiviral Agents / Q000627:therapeutic use*; D018122:B7-1 Antigen / Q000096:biosynthesis* / Q000276:immunology; D015415:Biomarkers / Q000097:blood; D003713:Dendritic Cells / Q000276:immunology; D004337:Drug Carriers; D005260:Female; D016174:Hepacivirus / Q000276:immunology; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D013601:T-Lymphocytes / Q000276:immunology
D000998:Antiviral Agents; D018122:B7-1 Antigen; D015415:Biomarkers; D004337:Drug Carriers; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a